Web Analytics

3 Latest Announced Rounds

  • $8,500,000
    Series A

    2 Investors

    Software Development
    Apr 17th, 2026
  • $17,000,000
    Series A

    2 Investors

    Hospital & Health Care
    Apr 17th, 2026
  • $2,750,000
    Pre-Seed

    2 Investors

    Technology, Information and Internet
    Apr 17th, 2026
$1,935.65M Raised in 48 Funding Rounds in the past 7 Days - View All

Funding Round Profile

GRO Biosciences

start up
United States - Boston, MA
  • 23/07/2024
  • Series B
  • $60,300,000

GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.


Related People

Dan MandellCo Founder

Dan Mandell United States - Boston, Massachusetts

Expanding the amino acid alphabet to make better medicines. Experienced Chief Executive Officer and scientist with a demonstrated history of technology development. Strong business development professional skilled in Computational Biology, Protein Chemistry, Entrepreneurship, Molecular Biology, and Metabolic Engineering.